Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
GLP-1 agonists are a class of drugs originally developed to treat diabetes but have been shown to be helpful for weight loss. Now a new study looks at whether their use reduces the risk of obesity related cancers. William Nelson, …
How are one class of diabetes drugs related to cancer risk? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:01 — 1.4MB)
Subscribe: RSS
Making CAR-T cells from donor bone marrow already used to treat someone’s cancer helped rein in cancer recurrence, a new study shows. Kimmel Cancer Center director William Nelson at Johns Hopkins says this is one more place where an expansion …
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
CAR-T cells developed from bone marrow donors whose bone marrow had already been used to treat someone’s cancer may be able to rein in cancer recurrence, a new study finds. Johns Hopkins Kimmel Cancer Center director William Nelson says this …
Can donor CAR-T cells have an impact on cancer treatment? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
Specially engineered T cells, one component of immune cells in your body, are called CAR-T cells, and for several years now have been used to treat blood cancers and some other conditions, with some success. William Nelson, director of the …
Are CAR-T cells coming into their own as therapeutic agents? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
In trying to discern factors that may account for colorectal cancer incidence in younger people many diet and lifestyle factors fell short, a new study finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, points toward insulin …
